Literature DB >> 9007311

Familial Alzheimer's disease co-segregates with a Met146I1e substitution in presenilin-1.

P Jørgensen1, C Bus, N Pallisgaard, M Bryder, A L Jørgensen.   

Abstract

The presenilin-1 (PS-1)/S 182 gene at chromosome 14q24.3 is, when mutated, the most common disease gene in autosomal dominant early-onset Alzheimer's disease. Substitution of methionine 146 of the gene product for either valine or leucine co-segregates with Alzheimer's disease with the age of onset in the late thirties or early forties. Here we describe a new substitution of methionine 146 for isoleucine that co-segregates with Alzheimer's disease with age of the onset in the early forties. All identified missense mutations in methionine codon 146 replace one hydrophobic amino acid (Met) with another (Val, Leu, Ile) and correspond to any nucleotide change at the first or third position of the codon. Second position mutations invariably lead to replacement of the hydrophobic methionine with a hydrophilic amino acid that may severely affect the function of the protein. The fact that no second position mutations have been identified so far may support the hypothesis that the protein product of PS-1 plays a crucial role during development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9007311

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis.

Authors:  Sadequl Islam; Yang Sun; Yuan Gao; Tomohisa Nakamura; Arshad Ali Noorani; Tong Li; Philip C Wong; Noriyuki Kimura; Etsuro Matsubara; Kensaku Kasuga; Takeshi Ikeuchi; Taisuke Tomita; Kun Zou; Makoto Michikawa
Journal:  J Neurosci       Date:  2022-01-05       Impact factor: 6.709

Review 3.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

4.  An Aberrant Phosphorylation of Amyloid Precursor Protein Tyrosine Regulates Its Trafficking and the Binding to the Clathrin Endocytic Complex in Neural Stem Cells of Alzheimer's Disease Patients.

Authors:  Ebbe T Poulsen; Filomena Iannuzzi; Helle F Rasmussen; Thorsten J Maier; Jan J Enghild; Arne L Jørgensen; Carmela Matrone
Journal:  Front Mol Neurosci       Date:  2017-03-15       Impact factor: 5.639

5.  Mutational analysis in familial Alzheimer's disease of Han Chinese in Taiwan with a predominant mutation PSEN1 p.Met146Ile.

Authors:  Yung-Shuan Lin; Chih-Ya Cheng; Yi-Chu Liao; Chen-Jee Hong; Jong-Ling Fuh
Journal:  Sci Rep       Date:  2020-11-13       Impact factor: 4.379

6.  Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.

Authors:  Selina Wray; Matthew Self; Patrick A Lewis; Jan-Willem Taanman; Natalie S Ryan; Colin J Mahoney; Yuying Liang; Michael J Devine; Una-Marie Sheerin; Henry Houlden; Huw R Morris; Daniel Healy; Jose-Felix Marti-Masso; Elisavet Preza; Suzanne Barker; Margaret Sutherland; Roderick A Corriveau; Michael D'Andrea; Anthony H V Schapira; Ryan J Uitti; Mark Guttman; Grzegorz Opala; Barbara Jasinska-Myga; Andreas Puschmann; Christer Nilsson; Alberto J Espay; Jaroslaw Slawek; Ludwig Gutmann; Bradley F Boeve; Kevin Boylan; A Jon Stoessl; Owen A Ross; Nicholas J Maragakis; Jay Van Gerpen; Melissa Gerstenhaber; Katrina Gwinn; Ted M Dawson; Ole Isacson; Karen S Marder; Lorraine N Clark; Serge E Przedborski; Steven Finkbeiner; Jeffrey D Rothstein; Zbigniew K Wszolek; Martin N Rossor; John Hardy
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.